Holger Fuchs
Birkendorfer Str. 65
Biberach An Der Riss, BW 88397, Germany
Biberach An Der Riss, BW 88397, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Injected Eye, Fellow Eye and Systemic Pharmacokinetic Modeling of Intravitreally Administered Bevacizumab.
Journal: Molecular pharmaceutics
Published: April 02, 2026
AAV-norrin gene therapy rescues retinal defects in mice with Norrie disease and oxygen-induced retinopathy.
Journal: Molecular therapy. Advances
Published: February 23, 2026
The Injection of Gels Through an Intact Annulus Maintains Biomechanical Performance without Extrusion Risk.
Journal: Gels (Basel, Switzerland)
Published: February 29, 2024
A Comprehensive Immunocapture-LC-MS/MS Bioanalytical Approach in Support of a Biotherapeutic Ocular PK Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 07, 2023
Characterization and Validation of In Vitro and In Vivo Models to Investigate TNF-α-Induced Inflammation in Retinal Diseases.
Journal: Translational vision science & technology
Published: May 17, 2022
Factors That Can Prolong Ocular Treatment Duration in Age-Related Macular Degeneration.
Journal: Ophthalmic research
Published: April 04, 2022
Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.
Journal: Pharmaceutical research
Published: November 24, 2021
A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance.
Journal: Journal of neurochemistry
Published: October 30, 2021
AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice.
Journal: Translational vision science & technology
Published: September 14, 2021
Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys - Evidence for half-life extension by albumin.
Journal: Experimental eye research
Published: October 23, 2020
Last Updated: 09/26/2026